Bookmark and Share
nuclear receptor subfamily 5 group A member 2.. [gi:4504343] - Target BioActivity Data
Also known as: nuclear receptor subfamily 5 group A member 2 isoform 2 [Homo sapiens].
Filters: All Data » Active      
Filter selected
BioActivity Outcomes:
Active(2594)
 
 
BioAssay Types:
Screening(2420)
 
 
Confirmatory(153)
 
 
BioActivity Types:
IC50(153)
 
 
Substance Types:
Chemical(2594)
 
 
Data download

Chemical Probe    Active    Inactive    Inconclusive    Unspecified   

Total Bioassays: 8    Data Row: 2594   Total Pages: 52   Display: Page     
Sort: [Click the result table header to sort]
#StructureSubstanceCompoundActivityBioAssayLinks
OutcomeTypeValue [μM]
1
[SID160644425]
[CID4789729]
IC50 0.0164Late stage luminescence-based cell-based high throughput dose response assay for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) [AID651976, Type: confirmatory]
View
2
[SID93375307]
[CID45382271]
Average IC50 0.11Center Based Initiative to identify novel inverse agonists of the liver receptor homolog-1 (LRH1; NR5A2): Luminescence-based dose response assay to identify LRH1 inhibitors (Cyp19 aromatase-luciferase reporter) [AID488782, Type: confirmatory]
View
3
[SID26727554]
[CID9566278]
IC50 0.14349Luminescence-based cell-based high throughput dose response assay for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) [AID651970, Type: confirmatory]
View
4
[SID49640875]
[CID958637]
IC50 0.14761Luminescence-based cell-based high throughput dose response assay for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) [AID651970, Type: confirmatory]
View
5
[SID160644426]
[CID774017]
IC50 0.14762Late stage luminescence-based cell-based high throughput dose response assay for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) [AID651976, Type: confirmatory]
View
6
[SID160644434]
[CID952237]
IC50 0.14762Late stage luminescence-based cell-based high throughput dose response assay for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) [AID651976, Type: confirmatory]
View
7
[SID49825032]
[CID8069390]
IC50 0.16785Luminescence-based cell-based high throughput dose response assay for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) [AID651970, Type: confirmatory]
View
8
[SID57256177]
[CID4789729]
IC50 0.16881Luminescence-based cell-based high throughput dose response assay for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) [AID651970, Type: confirmatory]
View
9
[SID26730794]
[CID9566279]
IC50 0.19793Luminescence-based cell-based high throughput dose response assay for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) [AID651970, Type: confirmatory]
View
10
[SID49821770]
[CID4911805]
IC50 0.29186Luminescence-based cell-based high throughput dose response assay for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) [AID651970, Type: confirmatory]
View
11
[SID92092843]
[CID45100448]
Average IC50 0.32Center Based Initiative to identify novel inverse agonists of the liver receptor homolog-1 (LRH1; NR5A2): Luminescence-based dose response assay to identify LRH1 inhibitors (Cyp19 aromatase-luciferase reporter) [AID488782, Type: confirmatory]
View
12
[SID160644473]
[CID2948274]
IC50 0.38559Late stage luminescence-based cell-based high throughput dose response assay for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) [AID651976, Type: confirmatory]
View
13
[SID92092844]
[CID45100455]
Average IC50 0.43Center Based Initiative to identify novel inverse agonists of the liver receptor homolog-1 (LRH1; NR5A2): Luminescence-based dose response assay to identify LRH1 inhibitors (Cyp19 aromatase-luciferase reporter) [AID488782, Type: confirmatory]
View
14
[SID3712332]
[CID2094416]
IC50 0.43717Luminescence-based cell-based high throughput dose response assay for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) [AID651970, Type: confirmatory]
View
15
[SID17414198]
[CID1287749]
IC50 0.44283Luminescence-based cell-based high throughput dose response assay for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) [AID651970, Type: confirmatory]
View
16
[SID160644484]
[CID4147163]
IC50 0.44285Late stage luminescence-based cell-based high throughput dose response assay for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) [AID651976, Type: confirmatory]
View
17
[SID160644485]
[CID7502918]
IC50 0.44285Late stage luminescence-based cell-based high throughput dose response assay for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) [AID651976, Type: confirmatory]
View
18
[SID160644486]
[CID7855787]
IC50 0.44285Late stage luminescence-based cell-based high throughput dose response assay for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) [AID651976, Type: confirmatory]
View
19
[SID160644493]
[CID24892601]
IC50 0.44285Late stage luminescence-based cell-based high throughput dose response assay for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) [AID651976, Type: confirmatory]
View
20
[SID160644503]
[CID2089406]
IC50 0.44285Late stage luminescence-based cell-based high throughput dose response assay for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) [AID651976, Type: confirmatory]
View
21
[SID160644457]
[CID958637]
IC50 0.44285Late stage luminescence-based cell-based high throughput dose response assay for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) [AID651976, Type: confirmatory]
View
22
[SID160644463]
[CID4900820]
IC50 0.44285Late stage luminescence-based cell-based high throughput dose response assay for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) [AID651976, Type: confirmatory]
View
23
[SID160644465]
[CID4905846]
IC50 0.44285Late stage luminescence-based cell-based high throughput dose response assay for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) [AID651976, Type: confirmatory]
View
24
[SID160644415]
[CID24892565]
IC50 0.44285Late stage luminescence-based cell-based high throughput dose response assay for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) [AID651976, Type: confirmatory]
View
25
[SID49726618]
[CID5153388]
IC50 0.45015Luminescence-based cell-based high throughput dose response assay for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) [AID651970, Type: confirmatory]
View
26
[SID26727363]
[CID9566277]
IC50 0.49455Luminescence-based cell-based high throughput dose response assay for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) [AID651970, Type: confirmatory]
View
27
[SID92092833]
[CID1484049]
Average IC50 0.538Center Based Initiative to identify novel inverse agonists of the liver receptor homolog-1 (LRH1; NR5A2): Luminescence-based dose response assay to identify LRH1 inhibitors (Cyp19 aromatase-luciferase reporter) [AID488782, Type: confirmatory]
View
28
[SID93375308]
[CID45382279]
Average IC50 0.57Center Based Initiative to identify novel inverse agonists of the liver receptor homolog-1 (LRH1; NR5A2): Luminescence-based dose response assay to identify LRH1 inhibitors (Cyp19 aromatase-luciferase reporter) [AID488782, Type: confirmatory]
View
29
[SID14746309]
[CID5346844]
IC50 0.57813Luminescence-based cell-based high throughput dose response assay for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) [AID651970, Type: confirmatory]
View
30
[SID49726028]
[CID6484709]
IC50 0.59434Luminescence-based cell-based high throughput dose response assay for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) [AID651970, Type: confirmatory]
View
31
[SID160644492]
[CID18579402]
IC50 0.67298Late stage luminescence-based cell-based high throughput dose response assay for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) [AID651976, Type: confirmatory]
View
32
[SID160644446]
[CID5243996]
IC50 0.67677Late stage luminescence-based cell-based high throughput dose response assay for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) [AID651976, Type: confirmatory]
View
33
[SID51089408]
[CID3245562]
IC50 0.73177Late stage luminescence-based cell-based high throughput dose response assay for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) [AID651976, Type: confirmatory]
View
34
[SID160644439]
[CID652603]
IC50 0.77869Late stage luminescence-based cell-based high throughput dose response assay for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) [AID651976, Type: confirmatory]
View
35
[SID89649733]
[CID44825215]
Average IC50 0.921Center Based Initiative to identify novel inverse agonists of the liver receptor homolog-1 (LRH1; NR5A2): Luminescence-based dose response assay to identify LRH1 inhibitors (Cyp19 aromatase-luciferase reporter) [AID488782, Type: confirmatory]
View
36
[SID160644427]
[CID3264499]
IC50 0.929Late stage luminescence-based cell-based high throughput dose response assay for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) [AID651976, Type: confirmatory]
View
37
[SID93375309]
[CID45382284]
Average IC50 1Center Based Initiative to identify novel inverse agonists of the liver receptor homolog-1 (LRH1; NR5A2): Luminescence-based dose response assay to identify LRH1 inhibitors (Cyp19 aromatase-luciferase reporter) [AID488782, Type: confirmatory]
View
38
[SID160644422]
[CID2523069]
IC50 1.064Late stage luminescence-based cell-based high throughput dose response assay for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) [AID651976, Type: confirmatory]
View
39
[SID85786758]
[CID7080823]
Average IC50 1.1Center Based Initiative to identify novel inverse agonists of the liver receptor homolog-1 (LRH1; NR5A2): Luminescence-based dose response assay to identify LRH1 inhibitors (Cyp19 aromatase-luciferase reporter) [AID488782, Type: confirmatory]
View
40
[SID160644416]
[CID7151547]
IC50 1.13Late stage luminescence-based cell-based high throughput dose response assay for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) [AID651976, Type: confirmatory]
View
41
[SID4258347]
[CID1091676]
IC50 1.133Luminescence-based cell-based high throughput dose response assay for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) [AID651970, Type: confirmatory]
View
42
[SID49820720]
[CID24818137]
IC50 1.153Luminescence-based cell-based high throughput dose response assay for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) [AID651970, Type: confirmatory]
View
43
[SID160644480]
[CID8069390]
IC50 1.248Late stage luminescence-based cell-based high throughput dose response assay for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) [AID651976, Type: confirmatory]
View
44
[SID85271691]
[CID3279586]
IC50 1.31Luminescence-based cell-based high throughput dose response assay for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) [AID651970, Type: confirmatory]
View
45
[SID49829017]
[CID4905846]
IC50 1.312Luminescence-based cell-based high throughput dose response assay for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) [AID651970, Type: confirmatory]
View
46
[SID863876]
[CID665128]
IC50 1.328Luminescence-based cell-based high throughput dose response assay for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) [AID651970, Type: confirmatory]
View
47
[SID3711897]
[CID2571013]
IC50 1.328Luminescence-based cell-based high throughput dose response assay for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) [AID651970, Type: confirmatory]
View
48
[SID26730370]
[CID2799295]
IC50 1.329Luminescence-based cell-based high throughput dose response assay for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) [AID651970, Type: confirmatory]
View
49
[SID99358794]
[CID46903543]
IC50 1.329Luminescence-based cell-based high throughput dose response assay for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) [AID651970, Type: confirmatory]
View
50
[SID160644481]
[CID4902523]
IC50 1.329Late stage luminescence-based cell-based high throughput dose response assay for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) [AID651976, Type: confirmatory]
View